Old Web
English
Sign In
Acemap
>
authorDetail
>
Suzanne Pryor-Tillotson
Suzanne Pryor-Tillotson
Merck & Co.
Medicine
Bone remodeling
Internal medicine
Osteoporosis
Bone resorption
3
Papers
848
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women
1997
The American Journal of Medicine
John L. Stock
Norman H. Bell
Charles H. Chesnut
Kristine E. Ensrud
Harry K. Genant
Steven T. Harris
Michael R. McClung
Singer F
Robert A. Yood
Suzanne Pryor-Tillotson
L. Wei
Arthur C. Santora
Show All
Source
Cite
Save
Citations (141)
Resolution of alendronate effects on bone turnover and BMD after multi-year treatment of osteoporotic women
1996
Osteoporosis International
John L. Stock
Norman H. Bell
Suzanne Pryor-Tillotson
L. Wei
Arthur C. Santora
Show All
Source
Cite
Save
Citations (3)
Esophagitis Associated with the Use of Alendronate
1996
The New England Journal of Medicine
Piet C. de Groen
Dieter Lubbe
Laurence J. Hirsch
Anastasia G. Daifotis
Wendy P. Stephenson
Debra Freedholm
Suzanne Pryor-Tillotson
Mitchel J. Seleznick
Haim Pinkas
Kenneth K. Wang
Show All
Source
Cite
Save
Citations (704)
1